Insomnia in schizophrenia is rarely solved by a sleep medication alone. The most reliable interventions are addressing the underlying illness, fixing circadian rhythm, and using CBT for insomnia. But medications still play a real role, especially in the short term, and the menu of options used in schizophrenia is broader than most people realise. This guide walks through the most common ones — what they are, when they help, and where the trade-offs sit.
Trazodone, melatonin, hydroxyzine, and mirtazapine are the most commonly used sleep medications in schizophrenia; benzodiazepines and Z-drugs are used cautiously; the right choice depends on the kind of insomnia and what is already on board.
Before reaching for a sleep medication
A few questions tend to come first:
- Is the antipsychotic itself contributing — through activation, akathisia, or wrong dose timing?
- Is there an active psychotic process making sleep impossible until it is treated?
- Is sleep apnea, restless legs syndrome, or another sleep disorder present?
- Is depression or anxiety driving the sleep loss?
- Has CBT-I been tried? It is the first-line treatment for chronic insomnia in the general population and works in psychosis too.
Working through these usually shapes the medication choice.
Trazodone
Trazodone is an older antidepressant rarely used at antidepressant doses any more, but very widely used at low doses (typically 25–100 mg) for sleep. It is one of the most common sleep choices in schizophrenia because:
- It is not addictive and not a controlled substance
- It promotes both sleep onset and sleep maintenance
- It does not generally suppress REM
- It is inexpensive and widely available
Things to be aware of:
- Morning grogginess at higher doses
- Orthostatic hypotension — important if your antipsychotic also lowers blood pressure (clozapine, quetiapine)
- Rare risk of priapism in men — must be discussed
- QT-interval considerations when combined with other QT-prolonging medications
Melatonin
Melatonin is the body's natural circadian signal. As a supplement, it has two distinct uses that often get confused:
- Circadian shifting — low doses (0.3–1 mg) taken several hours before desired bedtime, to advance the body clock
- Sleep promotion — slightly higher doses (1–3 mg) taken closer to bedtime
Melatonin's effect is modest but real. It is especially helpful for delayed sleep phase, jet lag, and shift work. There is no major interaction with most antipsychotics. Higher doses (5–10 mg) are not more effective and may simply produce next-day grogginess.
In schizophrenia specifically, some research has explored melatonin as an adjunct for sleep and for metabolic side effects of antipsychotics, with mixed but generally encouraging results.
Hydroxyzine
Hydroxyzine is an antihistamine with anxiolytic and sedative effects. It is often used short-term for both anxiety and sleep, particularly when benzodiazepines are being avoided. Doses for sleep are typically 25–50 mg at bedtime.
Pros: not addictive, fast-acting, useful when anxiety drives the sleep loss.
Cons: anticholinergic side effects (dry mouth, constipation, urinary retention) which compound on top of antipsychotics that already have anticholinergic effects. Tolerance to the sleep effect can develop. Caution in older adults due to cognitive effects.
Mirtazapine
Mirtazapine is an antidepressant that is strongly sedating at low doses (7.5–15 mg). It is occasionally used in schizophrenia both as a sleep aid and as an adjunct to antipsychotics — there is some evidence it can help with negative symptoms, weight loss in selected patients, and akathisia. See mirtazapine augmentation.
Trade-offs include weight gain (mirtazapine increases appetite, which is a problem stacked on top of antipsychotics), sedation that can persist into the day, and rare risk of agranulocytosis (worth noting in patients also on clozapine).
Benzodiazepines
Benzodiazepines (lorazepam, clonazepam, diazepam) are sometimes used for short periods in schizophrenia — especially during acute episodes when severe insomnia or agitation needs immediate control. See benzodiazepines in acute psychosis.
Long-term use for insomnia is generally avoided because of:
- Tolerance — the sleep effect fades over weeks to months
- Dependence and difficult withdrawal
- Cognitive effects
- Falls in older adults
- Respiratory suppression when combined with other sedatives
Z-drugs (zolpidem, zopiclone, eszopiclone)
Z-drugs are commonly prescribed for general insomnia. They are used cautiously in schizophrenia because of dependence risk, sleepwalking and complex sleep behaviours, and limited evidence in this population. They can have a role for selected patients short-term.
Suvorexant and other orexin antagonists
Newer dual orexin receptor antagonists (suvorexant, lemborexant, daridorexant) work by blocking the wakefulness signal rather than promoting sedation. They have less abuse potential than benzodiazepines and Z-drugs. Evidence in schizophrenia specifically is still developing but the mechanism is appealing for patients on multiple sedating medications.
Antipsychotics used for sleep
It is not uncommon to see low-dose quetiapine prescribed purely for sleep — for example, 25–50 mg at bedtime. This practice is controversial. Even at low doses, quetiapine can cause weight gain, metabolic changes, and rare serious side effects, and the evidence that it is more effective than safer options is weak. The American Academy of Sleep Medicine and groups like NICE generally do not recommend antipsychotics for primary insomnia in people who do not otherwise need them.
For people already taking quetiapine for schizophrenia, however, timing the dose close to bedtime to take advantage of its sedation is common and reasonable.
Things to avoid
- Alcohol as a sleep aid — destroys REM, fragments sleep, worsens psychosis risk
- Cannabis — may help short-term sleep onset but worsens long-term sleep architecture and is a known psychosis risk factor
- Diphenhydramine (Benadryl) chronically — anticholinergic burden, cognitive effects, especially in older adults
- Combining multiple sedatives without medical guidance — risk of severe sedation, falls, and respiratory effects
A new sleep medication produces severe morning grogginess, sleepwalking or complex sleep behaviours, dizziness on standing, or worsening of psychotic symptoms. Some of these effects are manageable; some require stopping the medication.
What to talk to your prescriber about
- Whether the insomnia is sleep onset, sleep maintenance, or both
- What antipsychotic and other medications are already on board, and their timing
- Any history of substance use, which shapes safer choices
- Specific constraints — driving early in the morning, low blood pressure, weight concerns
- Whether CBT-I is available locally or by telehealth
- How long the medication is intended to be used and what the exit plan looks like
The bigger picture
Sleep medications in schizophrenia are tools, not cures. The most durable improvements come from treating the underlying illness, repairing circadian rhythm, and learning the skills that CBT-I teaches. Medication helps bridge difficult stretches, manage acute episodes, and unlock the energy needed to do the rest of the work. Used thoughtfully, with a prescriber who knows your full picture, they can be genuinely valuable.
This article is for educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a qualified mental health professional. If you or someone you know is in crisis, call or text 988 in the US, or your local emergency number.